148 related articles for article (PubMed ID: 3141056)
1. Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.
Katano M; Yamamoto H; Mizoguchi T; Hisatsugu T
Cancer Immunol Immunother; 1988; 27(3):198-204. PubMed ID: 3141056
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of TGIF and interferon gamma (IFN-gamma) on tumor cell growth. TGIF and IFN-gamma.
Katano M; Yamamoto H; Nakamura M; Matsuo T; Hisatsugu T
Biotherapy; 1990; 2(1):33-40. PubMed ID: 2119202
[TBL] [Abstract][Full Text] [Related]
3. The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).
Katano M; Mizoguchi T; Yamamoto H; Nakamura M; Matsuo T; Hisatugu T; Kisu T; Yamaoka K; Tokunaga O
Jpn J Surg; 1990 Jan; 20(1):76-82. PubMed ID: 2304290
[TBL] [Abstract][Full Text] [Related]
4. A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy.
Katano M; Kubota E; Yamamoto H; Nakamura M; Matsuo T; Hisatsugu T; Katsuki T; Koga H; Ikezaki K; Tabuchi K
Biotherapy; 1991; 3(4):373-9. PubMed ID: 1786201
[TBL] [Abstract][Full Text] [Related]
5. Induction of endogenous tumor necrosis factor by OK-432 in ovarian cancer patients with ascites.
Mori H; Itoh N; Yamada Y; Tamaya T
Biotherapy; 1989; 1(3):123-31. PubMed ID: 2518374
[TBL] [Abstract][Full Text] [Related]
6. Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients.
Kubota E; Katano M; Kurokawa H; Imamura H; Katsuki T; Yamamoto H; Hisatsugu T; Nagumo F; Tadano J
J Craniomaxillofac Surg; 1993 Jan; 21(1):30-7. PubMed ID: 8445052
[TBL] [Abstract][Full Text] [Related]
7. Induction of endogenous cytokines in ascites of patients with ovarian cancer by OK-432, a streptococcal preparation.
Mori H; Itoh N; Yamada Y; Tamaya T
Asia Oceania J Obstet Gynaecol; 1989 Sep; 15(3):281-9. PubMed ID: 2512905
[TBL] [Abstract][Full Text] [Related]
8. Effect of soluble factors derived from oral cancer cells on the production of interferon-γ from peripheral blood mononuclear cells following stimulation with OK-432.
Ohe G; Sasai A; Uchida D; Tamatani T; Nagai H; Miyamoto Y
Oncol Rep; 2013 Aug; 30(2):945-51. PubMed ID: 23685791
[TBL] [Abstract][Full Text] [Related]
9. Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-gamma.
Bonavida B; Jewett A
Cell Immunol; 1989 Oct; 123(2):373-83. PubMed ID: 2507170
[TBL] [Abstract][Full Text] [Related]
10. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
Sekimoto M; Kokunai I; Shimano T; Kobayashi T; Takeda T; Haruna N; Yamamoto A; Mori T
J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012
[TBL] [Abstract][Full Text] [Related]
11. Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent.
Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Yoshida H; Matsuno T; Saito M; Sato M
Immunopharmacology; 2000 Sep; 49(3):363-76. PubMed ID: 10996034
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
Huang XL; Fan Z; Murayama T; Rinaldo C
Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
[TBL] [Abstract][Full Text] [Related]
14. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
[TBL] [Abstract][Full Text] [Related]
15. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Immunopharmacology; 1986 Apr; 11(2):79-86. PubMed ID: 3710767
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
Mori H; Itoh N; Tamaya T
Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
[TBL] [Abstract][Full Text] [Related]
17. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
18. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
19. Effects of the streptococcal preparation OK-432 on in vitro cytokine production of peripheral blood mononuclear cells in patients with chronic viral hepatitis.
Yamashiki M; Nishimura A; Takase K; Nakano T; Kosaka Y
J Clin Lab Immunol; 1992; 38(2):73-82. PubMed ID: 1343350
[TBL] [Abstract][Full Text] [Related]
20. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432].
Mizoguchi T; Katano M; Yamamoto H; Hisatsugu T
Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):794. PubMed ID: 3627102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
